Welcome to our dedicated page for Agilon Health news (Ticker: AGL), a resource for investors and traders seeking the latest updates and insights on Agilon Health stock.
agilon health, inc. provides a healthcare services platform that partners with primary care physician groups and health systems to transition senior patient care to a value-based Total Care Model. Company updates commonly cover Medicare Advantage members and ACO model beneficiaries on the agilon platform, payor contract economics, market exits, clinical programs, data and technology investments, and operating discipline within a Medicare-centric capitated care model.
News also includes quarterly and annual financial results, revenue, medical margin and Adjusted EBITDA guidance, conference participation, and governance changes such as CEO appointments and board membership. Recurring disclosures tie membership trends, payor alignment and clinical execution to the economics of agilon’s physician partnerships.
agilon health (AGL) is expanding its relationship with Family Practice Center (FPC) in Pennsylvania by adding FPC to one of agilon’s Senior Health Connect Accountable Care Organizations that participates in the Medicare Shared Savings Program.
FPC, which serves more than 200,000 patients, has a long-term agreement with agilon to transition certain Medicare patients to a full-risk, value-based care model beginning in 2024, aiming to reach more Traditional Medicare beneficiaries. Since 2021, agilon’s ACOs have generated more than $510 million in gross savings, including $125 million to the Medicare Trust Fund, and in 2024 achieved an average quality score of 96%, with four ACOs earning perfect scores and five recognized as high performers.
agilon health (NYSE: AGL) announced a revised presentation time for its participation at the 2026 Jefferies Healthcare Services and Technology Conference. The management team will now join a fireside chat at 4:00 p.m. ET on Monday, September 14, 2026. A simultaneous webcast and an on-demand replay will be accessible via the “Events & Presentations” section of agilon health’s investor relations website.
agilon health (NYSE: AGL) announced that its management team will participate in several upcoming healthcare conferences in September 2026, including the Wells Fargo 21st Annual Healthcare Conference on September 9, the Jefferies Healthcare Services and Technology Conference on September 14, and Deutsche Bank’s 2026 Healthcare Summit on September 16.
A live webcast is scheduled on the company’s investor relations website at 4:30 p.m. ET, with replays and applicable simultaneous webcasts accessible via the “Events & Presentations” section. Some meetings may not be webcast due to event format.
agilon health (NYSE: AGL) reported second quarter 2026 revenue of $1.49 billion, up 7% year over year, driven by higher burden-of-illness performance, payor contracting and pricing, partly offset by lower membership. Total members on the platform fell 10% to 549,000, reflecting a more selective, profitability-focused contracting strategy and prior market exits.
Gross profit improved to $107 million from a $52 million loss, and net income reached $18 million versus a $104 million loss a year earlier. Medical margin rose to $197 million, including favorable prior-period claims development, and Adjusted EBITDA improved to $70 million from negative $83 million. As of June 30, 2026, the company held $257 million in cash, cash equivalents and marketable securities and $32 million of total debt.
agilon raised full-year 2026 guidance, now expecting total revenues of $5.78–$5.86 billion, medical margin of $465–$505 million, and Adjusted EBITDA of $75–$95 million, up from prior ranges. Third-quarter 2026 guidance calls for revenue of $1.45–$1.48 billion, medical margin of $105–$115 million, and Adjusted EBITDA between $(5) million and $5 million.
agilon health (NYSE: AGL) reported that its eight REACH Accountable Care Organizations generated $229 million in gross savings in the 2024 ACO REACH performance year, a 13.6% gross savings rate, including $54 million in savings to the Medicare Trust Fund, while taking full risk for about 121,000 Traditional Medicare beneficiaries.
According to agilon health, the REACH ACOs achieved an average 96% quality score; four attained 100%, and five qualified for the High Performers Pool. Since joining ACO REACH in 2021, these ACOs have generated $510 million in gross savings, including $125 million to the Medicare Trust Fund. In 2024, agilon’s REACH ACOs included 1,500 primary care physicians across 13 communities in Hawaii, New York, North Carolina, Ohio, Pennsylvania and Texas, and five of its ACOs ranked among the top 20 Standard ACOs by gross savings rate.
agilon health (NYSE:AGL) will release its Q2 2026 financial results after market close on Wednesday, August 5, 2026. Management will host a conference call at 4:30 p.m. ET to discuss the results, with access via phone and live webcast on the investor relations website.
agilon health (NYSE:AGL) announced management participation in upcoming investor and industry conferences.
Executives will join the Truist Securities Healthcare Disruptors & Digital Health Conference in New York on June 23, 2026, and the Citizens Healthcare Services Forum in Boston on June 25, 2026, for panels and investor meetings.
agilon health (NYSE: AGL) reported first-quarter 2026 results and raised full-year guidance on May 6, 2026. Key first-quarter metrics: total revenues $1.42B, medical margin $149M, Adjusted EBITDA $54M, and total members 536,000 as of March 31, 2026.
The company raised 2026 guidance for total revenues, medical margin, and Adjusted EBITDA, and noted cash, cash equivalents and marketable securities of $303M and total debt of $32M.
agilon health (NYSE: AGL) appointed Tim O’Rourke as Chief Executive Officer and board member, effective May 7, 2026. He succeeds Ronald A. Williams, who will continue as Chairman of the Board.
O’Rourke brings 25+ years in payor and value-based care, including roles as President of Help at Home, 17 years at Humana, and CEO of Ascension Complete. The Board said the hire follows a year of operational and financial transformation and aims to build on improved data, contracting, and clinical capabilities.
agilon health (NYSE: AGL) will report Q1 2026 financial results after market close on Wednesday, May 6, 2026 and host a conference call at 4:30 p.m. ET.
According to the company, U.S. participants may dial (833) 461-5787, international participants +1 (585) 542-9983, participant code 206810108, and a simultaneous webcast and replay are available via agilon's Investor Relations "Events & Presentations" page.